---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-010716"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2025-03-18T23:59:59+00:00"
generated_at: "2026-05-24T13:35:40.459810+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma issues $33K convertible note to GS Capital Partners for working capital

## Summary
- Convertible promissory note with $33,000 principal, purchased at $30,000 (original issue discount of $3,000).
- Conversion price initially $6.00/share, drops to $3.00 if stock trades below $5.00 for 5 consecutive days.
- Note matures Nov 11, 2025, bears 8% interest; prepayment allowed at 110%-125% premiums within first 180 days.
- Proceeds from the private placement will be used for general working capital purposes.
- Issued to GS Capital Partners, LLC in reliance on Regulation D exemption under Section 4(a)(2).

## SEC filing metadata
- accession: 0001493152-25-010716
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2025-03-18T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315225010716/0001493152-25-010716-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315225010716/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-010716
- JSON: https://secwatch.observer/filing/0001493152-25-010716.json
- Plain text: https://secwatch.observer/filing/0001493152-25-010716.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.